Screens, Virtual Reality and Digital Addiction (EVADD) (EVADD)

March 14, 2024 updated by: Institut Rafael

Assessment of Screen Use and Impact of Excessive Smartphone Use on Adult Health

This is an observational study questionnaire-based. This study will be carried out to evaluate the methods of consumption (work/outside work), the characteristics of the tools used, the addictive risk, the consequences on mental and physical health and the impact on quality of life of people exposed to screens and smartphones.

A sample of 800 000 people will be used to learn about the entire French population. Participants will be asked to respond to an anonymous digital survey.

The ultimate goal of this work is to have quality information to help facilitate therapeutic efforts in support of those who may need it.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Inappropriate use of the smartphone is defined as excessive use of the technological tool interfering with social and/or professional activities causing negative consequences such as the alteration of certain cognitive functions such as attention. In addition, the excessive use of smartphones has generated a new form of digital symptoms such as NOMO or nomophobia (addiction to mobile phones by compulsive checking of new messages or social networks) and FOMO (fear of being excluded enriching social experiences, Fear of Missing Out).

From the perspective of social media addiction, research has shown that there is a fine line between habitual, frequent, unproblematic use and problematic and possibly addictive use of social media. Users who express symptoms and consequences traditionally associated with substance addiction (salience, mood changes, tolerance phenomenon, craving, withdrawal, relapse) could be addicted to social media.

Nowadays, abstinence from digital media and consumption cannot realistically be achieved in the context of SR addiction, as the internet and social media have become essential parts of our lives. Rather than shutting down social media altogether, therapy should focus on establishing controlled social media use and digital media awareness.

This study will be carried out to evaluate the methods of consumption (work/outside work), the characteristics of the tools used, the addictive risk, the consequences on mental and physical health and the impact on quality of life of people exposed to screens and smartphones.

A sample of 800 000 people will be used to learn about the entire French population. Participants will be asked to respond to an anonymous digital survey.

This is an observational study questionnaire-based. The ultimate goal of this work is not to overpathologize daily behaviours, but to have quality information to help facilitate therapeutic efforts in support of those who may need it.

Study Type

Observational

Enrollment (Actual)

21000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ile-de-France
      • Levallois-Perret, Ile-de-France, France, 92300
        • Institut Rafael

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

French population, adults, liste of members of the PRO-BTP insurance, volunteers

Description

Inclusion Criteria:

  • 18 years old or older (adult)
  • members of the PRO-BTP insurance (email list)
  • understanding French language

Exclusion Criteria:

  • less than 18 years old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
percentage of participants with addictive behaviour
Time Frame: 6 months
Percentage (%) of participants with more than 5 positive answers (YES) in the Smartphone Questionnaire containing 15 questions which suggests addictive behaviour
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
percentage of participants using video games
Time Frame: 6 months
Percentage (%) of participants who answered YES to the use of video games and analysis of the "Gaming Disorder-20 items" questionnaire from a scale of 1 (strongly disagree) to 5 (strongly agree)
6 months
Percentage of participants using online gambling
Time Frame: 6 months
Percentage (%) of participants who answered YES to the use online gambling and and analysis of the "online gambling - 9 items" questionnaire on a scale of 0 to 3 (0: Never, 1: Sometimes, 2: Most of the time, 3
6 months
Percentage of participants using social media networks
Time Frame: 6 months
Percentage (%) of participants who answered YES to the various questions on social networks , and analysis of the questionnaire "time spent on social media networks"
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 20, 2023

Primary Completion (Actual)

October 20, 2023

Study Completion (Actual)

January 15, 2024

Study Registration Dates

First Submitted

May 8, 2023

First Submitted That Met QC Criteria

May 8, 2023

First Posted (Actual)

May 16, 2023

Study Record Updates

Last Update Posted (Actual)

March 15, 2024

Last Update Submitted That Met QC Criteria

March 14, 2024

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • IR-2023/0001
  • 2023-A00312-43 (Other Identifier: National Agency for the Safety of Medicines and Health Products (ANSM, France))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Internet Addiction Disorder

Clinical Trials on survey

Subscribe